NeoTherapeutics’ Quarter Loss: $5.3 Million

NeoTherapeutics Inc., an Irvine drug development company, reported a net loss of $5.3 million, or 70 cents a share, for the third quarter, compared with a net loss of $3 million, or 54 cents a share, for the 1998 third quarter. No revenue was recorded.